Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cells
The invention is directed to methods for treating nervous system injury and disease, in particular traumatic brain injury and degenerative nervous system disease. Such methods utilize novel compositions, including but not limited to trophic factor-secreting extraembryonic cells (herein referred to as TSE cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as AMP cells) and conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or ACCS), each alone or in combination with each other and/or other agents.
1. A method for treating a closed-head traumatic brain injury in a patient in need thereof comprising the step of administering to the patient a therapeutically effective amount of a composition selected from the group consisting of Amnion-derived Cellular Cytokine Solution (ACCS) and Amnion-derived Multipotent Progenitor (AMP) cells.
2. The method of claim 1 wherein the ACCS is pooled ACCS.
3. The method of claim 1 wherein the closed-head traumatic brain injury is selected from the group consisting of Shaken Baby Syndrome, blast injury, blunt trauma, concussion, and concussion syndrome.
4. A method for relieving or ameliorating neurodegeneration in the brain caused by a closed-head traumatic brain injury in a patient in need thereof comprising the step of administering to the patient a therapeutically effective amount of a composition selected from the group consisting of ACCS or AMP cells.
5. The method of claim 4 wherein the ACCS is pooled ACCS.
6. The method of claim 4 wherein the closed-head traumatic brain injury is selected from the group consisting of Shaken Baby Syndrome, blast injury, blunt trauma, concussion, and concussion syndrome.